190 related articles for article (PubMed ID: 11302880)
1. Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment.
Castellino G; Cuadrado MJ; Godfrey T; Khamashta MA; Hughes GR
Ann Rheum Dis; 2001 May; 60(5):527-30. PubMed ID: 11302880
[TBL] [Abstract][Full Text] [Related]
2. Hemorrhagic complications of long-term anticoagulant therapy in 7 patients with systemic lupus erythematosus and antiphospholipid syndrome.
al-Sayegh FA; Ensworth S; Huang S; Stein HB; Klinkhoff AV
J Rheumatol; 1997 Sep; 24(9):1716-8. PubMed ID: 9292793
[TBL] [Abstract][Full Text] [Related]
3. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
[TBL] [Abstract][Full Text] [Related]
4. Cessation of oral anticoagulants in antiphospholipid syndrome.
Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
[TBL] [Abstract][Full Text] [Related]
5. Severe hemorrhagic corpus luteum complicating anticoagulation in antiphospholipid syndrome.
Yamakami LY; de Araujo DB; Silva CA; Baracat EC; de Carvalho JF
Lupus; 2011 Apr; 20(5):523-6. PubMed ID: 21138983
[TBL] [Abstract][Full Text] [Related]
6. Choice of anticoagulation in patients with low risk antiphospholipid syndrome.
Bakow BR; Phung Q; Rabinovich D; Olszewski AJ; Reagan JL
J Thromb Thrombolysis; 2023 Jul; 56(1):121-127. PubMed ID: 37219825
[TBL] [Abstract][Full Text] [Related]
7. The management of thrombosis in the antiphospholipid-antibody syndrome.
Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
[TBL] [Abstract][Full Text] [Related]
8. Direct oral anticoagulants in antiphospholipid syndrome: a real life case series.
Betancur JF; Bonilla-Abadía F; Hormaza AA; Jaramillo FJ; Cañas CA; Tobón GJ
Lupus; 2016 May; 25(6):658-62. PubMed ID: 26743321
[TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
Finazzi G; Marchioli R; Brancaccio V; Schinco P; Wisloff F; Musial J; Baudo F; Berrettini M; Testa S; D'Angelo A; Tognoni G; Barbui T
J Thromb Haemost; 2005 May; 3(5):848-53. PubMed ID: 15869575
[TBL] [Abstract][Full Text] [Related]
10. Massive ovarian haemorrhage complicating oral anticoagulation in the antiphospholipid syndrome: a report of three cases.
Crétel E; Cacoub P; Huong DL; Gompel A; Amoura Z; Piette JC
Lupus; 1999; 8(6):482-5. PubMed ID: 10483020
[TBL] [Abstract][Full Text] [Related]
11. Variability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: should the INR targets be higher?
Baquero-Salamanca M; Téllez-Arévalo AM; Calderon-Ospina C
BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25858939
[TBL] [Abstract][Full Text] [Related]
12. [Management of antiphospholipid syndrome].
Saadoun D; Piette JC; Wahl D; Costedoat-Chalumeau N
Rev Med Interne; 2012 Apr; 33(4):217-22. PubMed ID: 22360832
[TBL] [Abstract][Full Text] [Related]
13. [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
Kondrat'eva LV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Kovalenko TF; Ostriakova EV; Reshetniak TM
Ter Arkh; 2010; 82(5):33-9. PubMed ID: 20597268
[TBL] [Abstract][Full Text] [Related]
14. [Aspirin and antiphospholipid syndrome].
Hachulla E; Piette AM; Hatron PY; Blétry O
Rev Med Interne; 2000 Mar; 21 Suppl 1():83s-88s. PubMed ID: 10763209
[TBL] [Abstract][Full Text] [Related]
15. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.
Yelnik CM; Lambert M; Drumez E; Le Guern V; Bacri JL; Guerra MM; Laskin CA; Branch DW; Sammaritano LR; Morel N; Guettrot-Imbert G; Launay D; Hachulla E; Hatron PY; Salmon JE; Costedoat-Chalumeau N
Lupus; 2018 Sep; 27(10):1679-1686. PubMed ID: 30016929
[TBL] [Abstract][Full Text] [Related]
16. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
Malec K; Góralczyk T; Undas A
Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort.
Tan BE; Thong BY; Shivananda S; Han WW; Chng HH
Lupus; 2009 Jul; 18(8):752-8. PubMed ID: 19502274
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.
Rosove MH; Brewer PM
Ann Intern Med; 1992 Aug; 117(4):303-8. PubMed ID: 1637025
[TBL] [Abstract][Full Text] [Related]
19. [Warfarin in the treatment of antiphospholipid syndrome].
Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation withdrawal in antiphospholipid syndrome: a retrospective matched-control study.
Yelnik CM; Urbanski G; Drumez E; Caron C; Maillard H; Morell-Dubois S; Dubucquoi S; Launay D; Hachulla E; Hatron PY; Duhamel A; Lambert M
Lupus; 2018 Mar; 27(3):357-364. PubMed ID: 28728511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
